Task-specific Training for Patients With Acute Exacerbation of COPD
- Disease/Condition
- Pulmonary Disease, Chronic Obstructive
- Drug/Device/Intervention
- Task-specific training
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- Universidad de Granada
- Location
- Granada., Spain
- Phase
- N/A
- Start date
- Jan 15, 2024
- End date
- Aug 15, 2024
- Enrollment
- 68 participants
Modified Borg Scale,COPD Assessment Test (CAT),EuroQol-5D (EQ-5D),Chronic Obstructive Pulmonary Disease Knowledge Questionnaire (COPD-Q),Test of Adherence to Inhalers (TAI)
Patients with Chronic Obstructive Pulmonary Disease (COPD) experience a progressive
 deterioration in their quality of life. Task-specific training is a type of approach focused
 on chronic patients that allows the acquisition of new skills or improvement of lost skills.
 The overall objective of this project is to evaluate the effectiveness of a task-specific
 training program during hospitalization of patients with acute exacerbation of COPD. A
 randomized clinical trial will be conducted in patients hospitalized for COPD. Participants
 after signing informed consent will be randomized between the control group (standard
 treatment) and the intervention group (task-specific training program in addition to standard
 treatment). The task-specific training program is a multidisciplinary program divided into
 three blocks where specific tasks will be performed on symptom education, education of
 activities of daily living and improvement of physical capacity with the aim of reinforcing
 skills necessary for the self-management of COPD patients in the short, medium and long term.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06224075
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06224075 through Pure Global AI's free database. This phase not specified trial is sponsored by Universidad de Granada and is currently Not yet recruiting. The study focuses on Pulmonary Disease, Chronic Obstructive. Target enrollment is 68 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.